Ozempic and Wegovy Users Face Weight Regain Warning Within 18 Months Thursday, April 30, 2026 ozempic wegovy glp-1 weightloss obesity semaglutide weightregain diabetes cardiometabolic pharmaceutical Recent research reveals that individuals discontinuing GLP-1 medications such as Ozempic and Wegovy can expect to regain the weight they lost within approximately 18 months. An analysis of 37 previous studies involving 9,000 … Read More